Oscar Health, Inc. $OSCR is Glynn Capital Management LLC's Largest Position

Key Points

• Glynn Capital Management trimmed its Oscar Health stake by 4% in the fourth quarter, but the position remains its largest holding at about 13.5% of the portfolio.
• Several other institutional investors increased their Oscar Health positions, and 75.7% of the stock is owned by hedge funds and other institutions.
• Analysts are mixed on the stock: the consensus rating is Hold with an average price target of $19.22, while Oscar Health also reported stronger-than-expected quarterly EPS but slightly weaker revenue than forecast.

Glynn Capital Management LLC cut its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 4.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,740,597 shares of the company's stock after selling 115,428 shares during the period. Oscar Health comprises approximately 13.5% of Glynn Capital Management LLC's portfolio, making the stock its largest position. Glynn Capital Management LLC owned approximately 1.04% of Oscar Health worth $39,382,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Oscar Health by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company's stock valued at $297,477,000 after acquiring an additional 540,851 shares during the last quarter. Thrive Capital Management LLC lifted its position in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. American Century Companies Inc. lifted its position in Oscar Health by 89.0% in the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock valued at $100,298,000 after acquiring an additional 2,495,691 shares during the last quarter. Geode Capital Management LLC lifted its position in Oscar Health by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company's stock valued at $68,964,000 after acquiring an additional 116,430 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in Oscar Health by 0.9% in the third quarter. Dimensional Fund Advisors LP now owns 3,718,765 shares of the company's stock valued at $70,400,000 after acquiring an additional 31,785 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Jefferies Financial Group raised shares of Oscar Health from an "underperform" rating to a "hold" rating and boosted their price target for the company from $10.00 to $16.00 in a research report on Monday, April 20th. UBS Group boosted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a "neutral" rating in a research report on Thursday, May 7th. Zacks Research raised shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a report on Thursday, May 7th. Raymond James Financial raised shares of Oscar Health from a "market perform" rating to an "outperform" rating and set a $18.00 target price for the company in a report on Thursday, February 12th. Finally, Wall Street Zen raised shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a report on Saturday, May 9th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $19.22.

Insider Transactions at Oscar Health

In other news, CEO Mark T. Bertolini purchased 1,000,000 shares of the business's stock in a transaction that occurred on Monday, April 6th. The stock was purchased at an average cost of $11.92 per share, with a total value of $11,920,000.00. Following the completion of the acquisition, the chief executive officer directly owned 10,196,876 shares of the company's stock, valued at approximately $121,546,761.92. This trade represents a 10.87% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 100,000 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the transaction, the chief financial officer directly owned 1,216,660 shares of the company's stock, valued at $28,177,845.60. This represents a 7.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 24.39% of the stock is currently owned by corporate insiders.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $22.36 on Friday. The company has a 50-day simple moving average of $17.21 and a 200-day simple moving average of $15.73. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $25.58. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a market capitalization of $6.74 billion, a price-to-earnings ratio of -37.90, a PEG ratio of 1.54 and a beta of 2.34.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion during the quarter, compared to analysts' expectations of $4.90 billion. During the same period in the prior year, the company earned $0.92 earnings per share. The business's revenue was up 52.6% compared to the same quarter last year. On average, analysts predict that Oscar Health, Inc. will post 0.47 EPS for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.